Crestline Management’s Cidara Therapeutics CDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,952
Closed -$156K 246
2018
Q1
$156K Buy
+1,952
New +$156K 0.02% 209